Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica (BACHELOR Study)

NCT04027101 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT04027101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04027101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica (BACHELOR Study)
Lead sponsor
University Hospital, Brest
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2020
Completion date
August 30, 2023
Enrollment
34 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

polymyalgia rheumatic (pmr)